High-throughput nanodroplet screening for multi-component co-crystals

Technology
In development
University
Scouted & summarized by Halo AI

Newcastle University has developed a high-throughput encapsulated nanodroplet screening method (ENaCt) to accelerate the discovery of multi-component co-crystals. By using liquid-handling robotics to screen thousands of experiments with minimal sample requirements, this research-based approach enables the rapid identification and structural characterization of binary, ternary, and quaternary co-crystals, offering a significant advancement for pharmaceutical research and drug development.

Overview

High-throughput encapsulated nanodroplet screening for multi-component co-crystals is a research-based methodology developed by Newcastle University to accelerate the discovery of co-crystals. Co-crystals, which consist of two or more chemically inequivalent molecules, are vital in pharmaceutical development for improving the stability and bioavailability of active pharmaceutical ingredients. This method, known as Encapsulated Nanodroplet Crystallisation (ENaCt), addresses the resource-intensive nature of traditional co-crystal screening by enabling the rapid, parallel exploration of complex experimental landscapes using minimal sample quantities.

Technical specifications
  • Methodology: Utilizes liquid-handling robotics to perform high-throughput (HTP) nanoscale crystallisation experiments in 96-well plate formats.
  • Sample Efficiency: Requires only micrograms of material per experiment, allowing hundreds of unique conditions to be screened with minimal total substrate.
  • Process: Solutions of test molecules in organic solvents are encapsulated in inert oils, which mediate the rate of sample concentration through evaporation or diffusion.
  • Capabilities: Facilitates the discovery of binary, ternary, and quaternary higher-order co-crystals (HOCs).
  • Analysis: Produces high-quality single crystals suitable for structural elucidation via single crystal X-ray diffraction (SCXRD).
Technology readiness level

The technology is at TRL 6. It has been validated through extensive laboratory research and published studies, including the successful discovery of numerous novel binary, ternary, and quaternary co-crystal structures. The methodology has been demonstrated in collaboration with industry partners, such as AstraZeneca, to show its practical utility in accelerating drug development pipelines. While it is a proven research tool used in academic and collaborative settings, it is described as a developed method rather than a commercial product...

Generated Sep 27, 2026. Please verify key information.

About Newcastle University

Newcastle University is a comprehensive public research university in Newcastle upon Tyne, with broad academic and translational activity. Its city‑centre Newcastle Helix innovation district—developed with Newcastle City Council and Legal & General—co‑locates researchers with companies and hosts national innovation centres to enable fast collaboration. Deep integration with Newcastle upon Tyne Hospitals NHS Foundation Trust, supported by a joint research office, enables streamlined study setup, access to clinical populations, and end‑to‑end clinical translation. Research is backed by competitive funding from UKRI councils, the National Institute for Health and Care Research, major charities, the European Union, and industry. A dedicated technology transfer office supports IP, licensing, spinouts, and knowledge‑transfer partnerships.

Halo home
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.